Mapo Plasma
Mapo Plasma (Plazma.plus) is a Czech Republic-based private plasma collection operator that runs 10 physical donation centers across regional Czech cities, serving individual compensated plasma donors via direct-to-consumer scheduling through website, mobile app, and phone.
- Company typePrivate
- Founded2017
- HeadquartersProstejov, Czechia
- Headcount—
- GTM typeB2C
- OfferingServices
What Mapo Plasma does
Mapo Plasma, now operating under the Plazma.plus brand, is a Czech Republic-based for-profit private company founded in 2017 and domiciled in Prostějov. Its legal entity is Plazma Plus s.r.o., and it specializes in blood plasma donation and collection, operating a network of 10 physical collection centers distributed across regional Czech cities including Znojmo, Přerov, Písek, Zlín, Vyškov, Hradec Králové, Šumperk, Rychnov nad Kněžnou, Havířov, and Prostějov. The company underwent a full rebrand in late 2024, consolidating all sites under the unified Plazma.plus brand identity.
The company's core product is blood plasma collection services delivered through these physical centers, with a complementary mobile application (available on Google Play and Apple App Store) supporting donor appointment scheduling. The underlying operating model is direct-to-consumer: individual donors schedule plasma donation appointments via the website, mobile app, or a centralized phone line (+420 800 400 101), and donors are compensated for their contributions. From a technical perspective, the stack is light: the public-facing systems are a website (plazma.plus), a mobile app for scheduling, and phone-based customer service; no proprietary technology, AI/ML capabilities, patents, or third-party platform integrations are disclosed in the source data.
The business model is service-based plasma collection, with the company compensating donors and generating revenue through the downstream distribution of collected plasma to pharmaceutical and medical-industry buyers for use in plasma-derived therapies. No pricing, donor-compensation rates, or revenue figures are publicly disclosed. Customer segmentation is horizontal, targeting individual voluntary plasma donors across the Czech Republic, with no disclosed enterprise buyers, partnerships, awards, or institutional investors in the input material.
Mapo Plasma firmographics
Firmographics- Name
- Mapo Plasma
- Legal name
- Plazma Plus s.r.o
- Website
- https://mapoplasma.cz
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Short description
- Mapo Plasma (Plazma.plus) is a Czech Republic-based private plasma collection operator that runs 10 physical donation centers across regional Czech cities, serving individual compensated plasma donors via direct-to-consumer scheduling through website, mobile app, and phone.
- Ownership category
- akta.pro rank
Mapo Plasma industry classification
Industry- Product category
- Blood Plasma Collection Services
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
Keywords
Where Mapo Plasma is headquartered
LocationHeadquarters
- HQ city
- Prostejov
- HQ country
- Czechia
- HQ region
- Europe
Offices10 records
Markets served
Mapo Plasma business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Plasma Collection Services: Mapo Plasma / Plazma.plus operates plasma collection centers where they collect blood plasma from donors. The company compensates donors for their plasma donations and likely generates revenue through the distribution of collected plasma to pharmaceutical companies or medical facilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Mapo Plasma product offering
Product offeringCore offering
Mapo Plasma (now Plazma.plus) operates a network of 10 physical blood plasma collection centers across the Czech Republic, where individual donors donate blood plasma and receive compensation. The service is supported by a mobile application and website for appointment scheduling. Collected plasma is supplied onward to pharmaceutical and medical facilities for use in life-saving therapies.
Product overview
Plazma.plus (formerly Mapo Plasma) is a blood plasma collection service operated by Plazma Plus s.r.o., offering a network of 10 collection centers across the Czech Republic. The core offering is blood plasma donation services, supported by a mobile application for appointment booking available on Google Play and App Store.
Differentiator
Problem solved
Functional benefit
Products and services
- Plazma.plus Blood Plasma Collection Service Blood plasma donation and collection service operating 10 collection centers across the Czech Republic, where individual donors donate blood plasma in exchange for compensation. The collected plasma is supplied onward to pharmaceutical and medical facilities for the production of therapies. Formerly known as Mapo Plasma, the service was rebranded to Plazma.plus in late 2024.
- Plazma.plus Mobile Application
Companies that use Mapo Plasma
Customer profileSegments1 record
Ideal customer profiles1 record
Mapo Plasma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Mapo Plasma partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights3 records
Mapo Plasma competitors and assessment
Company assessmentDirect peers
- Grifols: Operates a global network of plasma donation centers (via its Biotest subsidiary) feeding its own fractionation business. Closely comparable business model to Mapo Plasma on the collection side, though vertically integrated downstream.
- Octapharma: Swiss-headquartered fractionator that also operates its own plasma collection centers across Europe and the US. Competes with Mapo Plasma for both donors and downstream fractionation supply.
- BioLife Plasma Services: US-focused plasma collection network owned by Takeda. Closely comparable operating model — paid donor centers, consumer-facing booking, and large-scale plasma collection — although geographically focused on North America.
- CSL Plasma: Largest global plasma collection network, operating hundreds of donor centers. Direct competitor to Mapo Plasma in the source-plasma collection value chain, with substantially greater scale and global reach.
- Biotest: German plasma fractionator (now part of Grifols) that operated plasma collection centers in Europe. Highly comparable on collection infrastructure and donor-compensation model.
- BPL (Bio Products Laboratory): UK-based plasma fractionator that operates dedicated plasma collection centers. Directly comparable to Mapo Plasma on the collection-services side of the value chain.
- Kedrion: Italian plasma-derived therapy manufacturer that operates plasma collection centers, including in Europe. Comparable as both a collector and a buyer of source plasma in the same European market as Mapo Plasma.
Others
- Plasma Protein Therapeutics Association (PPTA): Industry trade association representing the world's major plasma collectors and fractionators. Relevant as an ecosystem peer for understanding competitive dynamics, regulatory advocacy, and quality standards governing Mapo Plasma's operations.
Regional players
- Czech transfusion service (Ústřední vojenská nemocnice / VFN transfusion centers): Czech public-sector blood and plasma collection providers. Adjacent rather than directly competitive — they focus on whole-blood and recovered plasma for transfusion, whereas Mapo Plasma collects source plasma for fractionation — but they share donors and geographic footprint.
- Sanquin Plasma Products: Dutch blood and plasma organization collecting and fractionating plasma in the Netherlands and parts of Europe. Comparable operating model but focused on the Dutch/Benelux market rather than Central Europe.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Mapo Plasma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mapo Plasma leadership team
Management profileNumber of profiles
Mapo Plasma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mapo Plasma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mapo Plasma
What does Mapo Plasma do?
Mapo Plasma (now Plazma.plus) operates a network of 10 physical blood plasma collection centers across the Czech Republic, where individual donors donate blood plasma and receive compensation. The service is supported by a mobile application and website for appointment scheduling. Collected plasma is supplied onward to pharmaceutical and medical facilities for use in life-saving therapies.
Is Mapo Plasma a public or private company?
Mapo Plasma is a private company. It is classified as unknown and is currently operating.
When was Mapo Plasma founded?
Mapo Plasma was founded in 2017.
Where is Mapo Plasma based?
Mapo Plasma is headquartered in Prostejov, Czechia, in the Europe region.
How does Mapo Plasma make money?
One revenue line is on record: plasma Collection Services.
Who are Mapo Plasma's main competitors?
Direct peers on record are Grifols, Octapharma, BioLife Plasma Services, CSL Plasma, Biotest, BPL (Bio Products Laboratory) and Kedrion. Plasma Protein Therapeutics Association (PPTA) is listed as an others. Regional players are Czech transfusion service (Ústřední vojenská nemocnice / VFN transfusion centers) and Sanquin Plasma Products.
Does Mapo Plasma have an API?
No public API is recorded for Mapo Plasma.
What industry is Mapo Plasma in?
Mapo Plasma's product category is Blood Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers). Its NAICS code is 621991.